Intraoperative Molecular Imaging for Precision Cancer Surgery
*Corresponding Author:Received Date: Sep 02, 2024 / Published Date: Sep 30, 2024
Citation: Lada I (2024) Intraoperative Molecular Imaging for Precision Cancer Surgery. Cancer Surg, 9: 128.DOI: 10.4172/2573-542X.1000128
Copyright: 漏 2024 Lada I. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Abstract
Intraoperative molecular imaging (IMI) is a rapidly advancing technology that integrates molecular-level information with real-time surgical visualization, enabling precision tumor resection and improved surgical outcomes. By enhancing the ability to identify cancerous tissue during surgery, IMI helps surgeons to more accurately delineate tumors from healthy tissue, ensuring more complete resections. This article explores the applications, benefits, challenges, and future perspectives of IMI in cancer surgery. We discuss various imaging modalities, including fluorescence-guided surgery, positron emission tomography (PET), and intraoperative MRI, and how they contribute to better decision- making during tumor removal procedures.
